Cochrane Policy Manual
Amendments/additions
The pages within this Manual are updated individually as required.
All suggestions for amendments and improvements, please, to:
The Cochrane Operations Unit,
Summertown Pavilion, 18-24 Middle Way, Oxford, OX2 7LG, UK
Tel: +44 (0)1865 310138; Fax: +44 (0)1865 316023; E-mail: operations-unit@cochrane.org
- 1. CENTRAL ORGANISATION
- 1.1 Description of The Cochrane Collaboration
- 1.1.1 The Cochrane Operations Unit
- 1.1.2 Editor in Chief/Cochrane Editorial Unit
- 1.1.3 Special roles within The Cochrane Collaboration (with job descriptions)
- 1.1.3.1 Co-Chairs of the Steering Group
- 1.1.3.2 Members of the Steering Group
- 1.1.3.3 Company Secretary
- 1.1.3.4 Funding Arbiter
- 1.1.3.5 Ombudsmen
- 1.1.3.6 Publication Arbiter
- 1.1.3.7 Trading Company Directors
- 1.1.3.8 Cochrane Innovations Limited
- 1.1.3.9 Treasurer
- 1.1.3.10 CRG executives
- 1.1.3.11 Trials Search Co-ordinators' Executive - Remit
- 1.1.3.12 Methods Board and Methods Executive
- 1.1.3.13 Fields' Executive
- 1.1.3.14 Consumers' Executive
- 1.1.4 Core infrastructure: expectations of budget holders
- 1.2 Strategic Plan
- 1.3 Memorandum and Articles of Association
- 1.4 Communication
- 1.4.1 Websites
- 1.4.2 Mailing lists
- 1.4.3 The Collaboration’s Information Management System - Archie
- 1.4.4 Archie - Terms of use
- 1.4.5 Criteria for inclusion in Archie and/or access to the Entity Website Builder
- 1.4.6 Permission to access Collaboration-wide data in Archie
- 1.4.7 Newsletters
- 1.4.8 Guidelines for sending e-mail attachments
- 1.4.9 Cross-cultural team working within The Cochrane Collaboration
- 1.5 Support
- 1.1 Description of The Cochrane Collaboration
- 2. COCHRANE COLLABORATION POLICIES
- 2.1 General policies
- 2.1.1 Code of conduct for avoiding potential financial conflicts of interest
- 2.1.2 Avoidance of conflict of interest in reimbursing Steering Group expenses
- 2.1.3 Criteria for choosing the location of mid-year meetings of the Steering Group, Centre Directors, Entity Executives and related others
- 2.1.4 Cochrane Colloquia
- 2.1.5 Registering surveys with the Cochrane Operations Unit (COU)
- 2.1.6 Country names in Cochrane publications
- 2.1.7 Policy on indirect overhead costs
- 2.1.8 Policy on the granting of endorsements
- 2.1.9 Appointment of a proxy to attend a Steering Group meeting
- 2.1.10 Partnership policy of The Cochrane Collaboration
- 2.1.11 Inflation Rate Calculator
- 2.2 Publishing policies
- 2.2.1 Guiding principles for disseminating Cochrane Reviews
- 2.2.2 Cochrane Reviews (converting Protocols, updating/withdrawing)
- 2.2.2.1 Who is the audience for Cochrane Reviews?
- 2.2.2.2 Policy on updating Cochrane Reviews and converting Protocols
- 2.2.2.3 Policy on withdrawing Cochrane Protocols and Reviews
- 2.2.2.4 Plain language summaries
- 2.2.2.5 Process in the event of serious errors in published Cochrane Reviews
- 2.2.2.6 Access to archived Cochrane Reviews
- 2.2.3 The Cochrane Database of Systematic Reviews
- 2.2.4 Rationale for requiring Cochrane authors to publish in the Cochrane Database of Systematic Reviews first
- 2.2.5 Publication of versions of Cochrane Reviews in print journals
- 2.2.6 Royalties
- 2.2.7 Copyright (Licence for Publication forms)
- 2.2.7.1 Permission to republish Cochrane material in print
- 2.2.7.2 Copyright permission request form
- 2.2.7.3 Licence for Publication - Cochrane Reviews
- 2.2.7.4 Licence for Publication - Protocols for Cochrane Reviews
- 2.2.7.5 Declarations of Interest by Cochrane authors
- 2.2.7.6 Guideline for deceased authors
- 2.2.7.7 Addendum to licence for publication of a WHO manuscript as a Cochrane Protocol or Review
- 2.2.8 Access options for The Cochrane Library
- 2.2.9 Use of the Cochrane logo
- 2.2.9.1 Introduction
- 2.2.9.2 Who can use the logo without explicit permission?
- 2.2.9.3 Who should seek permission before using the symbol (with or without text)?
- 2.2.9.4 Use of modified version of the logo
- 2.2.9.5 What if someone seems to be using the symbol (with/without text) or name inappropriately?
- 2.2.10 Translation policies
- 2.2.11 How to cite our products
- 2.2.12 Withdrawal or suspension of complimentary copies of The Cochrane Library
- 2.2.13 Access to the Parent Database
- 2.2.14 Cochrane-Wiley book series proposals
- 2.2.15 Guidelines for managing reviews with overlapping scope
- 2.3 Commercial sponsorship policy
- 2.4 Annual prizes and awards
- 2.5 Fellowships, scholarships and bursaries
- 2.1 General policies
- 3. OPERATIONS
- 3.1 Steering Group
- 3.2 Cochrane Review Groups
- 3.2.1 Introduction
- 3.2.2 How Cochrane Review Groups form
- 3.2.2.1 What can I do?
- 3.2.2.2 Exploring areas of common interest
- 3.2.2.3 Contacting Cochrane Centres
- 3.2.2.4 Organizing exploratory meetings
- 3.2.2.5 Managing the politics
- 3.2.2.6 Considering the scope
- 3.2.2.7 Making the commitment
- 3.2.2.8 The Co-ordinating Editor
- 3.2.2.9 The Managing Editor (formerly 'Review Group Co-ordinator')
- 3.2.2.10 Forming an editorial team
- 3.2.2.11 The Feedback Editor
- 3.2.2.12 Identifying authors
- 3.2.2.13 Developing a specialized register of RCTs
- 3.2.2.14 Registering a Cochrane Review Group
- 3.2.2.15 Ensuring computing support
- 3.2.2.16 Publicising the Group’s existence
- 3.2.3 Producing and updating reviews
- 3.2.3.1 Fostering collaboration and co-operation
- 3.2.3.2 Developing protocols
- 3.2.3.3 Increasing trials register coverage
- 3.2.3.4 Providing technical support
- 3.2.3.5 Developing guidelines
- 3.2.3.6 Managing areas of common interest
- 3.2.3.7 Providing ‘space’ to conduct systematic reviews
- 3.2.3.8 Maintaining communication
- 3.2.4 Managing expectations: what does The Cochrane Collaboration expect of authors, and what can authors expect of The Cochrane Collaboration?
- 3.2.5 Personnel and support
- 3.2.6 Maintaining and managing a Cochrane Review Group
- 3.2.6.1 Establishing a refereeing policy
- 3.2.6.2 Policy on default statistics
- 3.2.6.3 Non-performance of authors
- 3.2.6.4 Avoiding duplication of reviews and protocols
- 3.2.6.5 Internal Cochrane Review Group policies
- 3.2.6.6 Dealing with conflicts within Groups
- 3.2.6.7 Liaising with Fields and Methods Groups
- 3.2.6.8 Maintaining an active list of authors and other contributors
- 3.2.6.9 Producing a newsletter
- 3.2.6.10 Reviewing the scope of the Cochrane Review Group
- 3.2.6.11 Performance and quality assessment of Cochrane Review Groups
- 3.2.7 Conclusion
- 3.2.8 Acknowledgements
- 3.2.9 Appendices
- 3.2.9.1 Agenda for an exploratory meeting to discuss formation of a Cochrane Review Group
- 3.2.9.2 Report of an exploratory meeting
- 3.2.9.3 Checklist for application to register a Cochrane Review Group
- 3.2.9.4 Example covering letter for application to register with The Cochrane Collaboration
- 3.2.9.5 Recruitment of a Managing Editor
- 3.2.9.6 Recruitment of a Trials Search Co-ordinator
- 3.2.9.7 Co-ordinating Editor job description and expectations of role
- 3.3 Centres
- 3.4 Fields
- 3.4.1 Introduction
- 3.4.2 The definition and role of Cochrane Fields
- 3.4.3 How Fields work
- 3.4.3.1 The functioning of Cochrane Fields
- 3.4.3.2 Identifying trials and developing a Specialised Register
- 3.4.3.3 Ensuring proper representation on Cochrane Review Groups
- 3.4.3.4 Acting as a channel of communication
- 3.4.3.5 Promoting the health care interests of Fields within The Cochrane Collaboration
- 3.4.3.6 Promoting the aims and work of The Cochrane Collaboration within the Field
- 3.4.3.7 Preparing specialised databases of systematic reviews
- 3.4.3.8 Identifying funding opportunities
- 3.4.4 Establishing a Cochrane Field
- 3.4.5 The registration process
- 3.4.6 Managing the module
- 3.4.7 Monitoring the performance of a Cochrane Field
- 3.4.8 The Consumer Network
- 3.4.9 Acknowledgements
- 3.5 Methods Groups
- 3.5.1 The role of Methods Groups
- 3.5.1.1 Providing policy advice
- 3.5.1.2 Serving as a forum for discussion
- 3.5.1.3 Ensuring that the Group functions as part of The Cochrane Collaboration
- 3.5.1.4 Providing training (elective core function)
- 3.5.1.5 Hosting a network of CRG-based methods individuals (elective core function)
- 3.5.1.6 Providing peer review (elective core function)
- 3.5.1.7 Providing specialist advice (elective core function)
- 3.5.1.8 Contributing to new products or lines of activity (elective core function)
- 3.5.1.9 Contributing to software development (elective core function)
- 3.5.1.10 Conducting Cochrane methodology reviews (elective core function)
- 3.5.1.11 Contributing to the Cochrane Methodology Register (elective core function)
- 3.5.1.12 Helping to monitor and improve the quality of Cochrane Reviews (elective core function)
- 3.5.1.13 Conducting methodological research (elective core function)
- 3.5.1.14 Communicating Cochrane methodology to external organizations (elective core function)
- 3.5.2 Registration and accountability
- 3.5.3 Co-ordination of Methods Groups
- 3.5.4 Improving methodological support in The Cochrane Collaboration
- Annex: Annual survey of members
- 3.5.1 The role of Methods Groups
- APPENDIX 1: Co-publication agreements/ correspondence with journal editors re publishing Cochrane reviews
- APPENDIX 2: Monitoring and Registration Committee
- A2.1. Introduction
- A2.2. Core functions of the Monitoring and Registration Committee
- A2.3 Composition of the Monitoring and Registration Committee
- A2.4 Objectives of the Monitoring and Registration Committee
- A2.5 Registration
- A2.6 Monitoring
- A2.6.1 Objectives of the monitoring process
- A2.6.2 Principles of monitoring
- A2.6.3 Monitoring process
- A2.6.4 Criteria for monitoring
- A2.6.5 Criteria for identifying entities about which the Monitoring and Registration Committee should be concerned
- A2.6.6 Strategies to help those entities experiencing particular difficulties
- A2.6.7 Examples of good practice
- A2.7 De-registration of an entity
- Annex A2.A: Requirements for registration by type of entity
- Annex A2.B: Registration process for new entities
- Annex A2.C: Major and minor changes to entities
- APPENDIX 3: Contact people at John Wiley & Sons Limited (Wiley-Blackwell)
- APPENDIX 4: The Cochrane Collaboration supports prospective registration of clinical trials
Download The Cochrane Policy Manual in PDF format.
Attention: Please note that this PDF version is generated nightly and thus may not reflect changes made in the last 24 hours.
How to cite this version:
The Cochrane Collaboration. The Cochrane Policy Manual [updated 8 May 2013].(www.cochrane.org/policy-manual/welcome) (accessed [date]).
The Cochrane Collaboration. The Cochrane Policy Manual [updated 8 May 2013].(www.cochrane.org/policy-manual/welcome) (accessed [date]).
Updated on: January 14, 2013, 12:37
Copyright © The Cochrane Collaboration
Comments for improvement or correction are welcome.
Email: web@cochrane.org
